Evidence map›Paper›PMID 42499792›Full record

ArticleO&G open2026

Vaginitis and Sexually Transmitted Infections Coinfections.

Elizabeth M Marlowe, Zhen Chen, Ky Van, Kyle Bukowski, Susan E Realegeno, Meghan W Starolis, Lance A Bare, Ashley Nenninger, Damian P Alagia

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in O&G open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elizabeth M MarloweQuest Diagnostics, Secaucus, New Jersey; and Hologic, Inc, San Diego, California.
Zhen ChenQuest Diagnostics, Secaucus, New Jersey; and Hologic, Inc, San Diego, California.
Ky VanQuest Diagnostics, Secaucus, New Jersey; and Hologic, Inc, San Diego, California.
Kyle BukowskiQuest Diagnostics, Secaucus, New Jersey; and Hologic, Inc, San Diego, California.
Susan E RealegenoQuest Diagnostics, Secaucus, New Jersey; and Hologic, Inc, San Diego, California.
Meghan W StarolisQuest Diagnostics, Secaucus, New Jersey; and Hologic, Inc, San Diego, California.
Lance A BareQuest Diagnostics, Secaucus, New Jersey; and Hologic, Inc, San Diego, California.
Ashley NenningerQuest Diagnostics, Secaucus, New Jersey; and Hologic, Inc, San Diego, California.
Damian P AlagiaQuest Diagnostics, Secaucus, New Jersey; and Hologic, Inc, San Diego, California.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the prevalence and risk of concurrent sexually transmitted infections (STIs),

methodsThis retrospective cross-sectional study included more than 1.5 million women 15 years of age or older who underwent molecular testing for BV, VVC,

resultsOverall BV and VVC positivity rates were 38.7% and 28.5%, respectively; 10.8% of patients were positive for both. Among BV+ women, 12.0% had at least one STI (10.9% with only one STI and 1.1% with two-four STIs), whereas among BV- women, 3.8% had at least one STI (3.6% with only one STI and 0.2% two-four STIs) (

conclusionAmong U.S. women presenting for vaginitis evaluation, BV is strongly and independently associated with increased risk of nonviral STI coinfection, whereas VVC is not. These findings support comprehensive STI testing in women with BV to optimize clinical management and to reduce reproductive health complications.

Identifiers

PMID42499792
PMCPMC13400018

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.